CCL19 and breast carcinoma: In the plasma of 2208L lung metastasis–bearing mice, we observed an abnormal upregulation of CCL19, which has been associated with breast cancer metastasis, and the expression level decreased with IACS-70654 treatment (64) (Supplemental Figure 7C).